News

Osteoarthritis is common in the UK, with nearly nine million adults over the age of 45 seeking treatment due to painful flare ...
Inhibiting FABP5 represents a unique mechanism of action with ART26.12 standing out as a first-in-class candidate in the field of pain management. The Phase 1 Single Ascending Dose (SAD) study was ...